Revolution Medicines Inc

Organisation

700 Saginaw Drive, Redwood City, CA, United States, 94063

Headquarters

Employees

Health Technology

Industry

Mark Goldsmith

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Price

Target

Revolution Medicines Inc (RVMD) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Revolution Medicines Inc (RVMD) share price will touch around $129.35 in next 12-months.

Currently 19 wall-street analysts regularly analyze the financials of Revolution Medicines Inc on a frequent basis to provide recommendations along with target share price. 19 analysts offering 12-month price forecasts for Revolution Medicines Inc (RVMD) have a share price target of $129.35. This median of share price forecast represents a 36.39% upside from the latest price of $94.84 as on 15.03.26.

Revolution Medicines Inc (RVMD) Share Price Forecast

Home

US Stocks

Revolution Medicines Inc (RVMD)

Revolution Medicines Inc Stock Forecast

Revolution Medicines Inc Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Revolution Medicines Inc (RVMD): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Revolution Medicines Inc's share price and its median forecast price. As on 15.03.26, the difference is -8.96%

Revolution Medicines Inc Forecast and Target Price

Revolution Medicines Inc (RVMD) Share Price Forecast

Revolution Medicines Inc (RVMD) Price vs Consensus Price Target

Revolution Medicines Inc (RVMD) Share Price Forecast v/s Share Price Today

Revolution Medicines Inc (RVMD): Difference between Current Price & Median Forecasted Price

Revolution Medicines Inc (RVMD) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price